Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
Have a question or advice regarding financial planning, retirement planning, buying a house, taxes, etc.? Try it here. Remember, please use this forum as a starting place for information, but please remember to consult a financial professional before making serious financial decisions. Please also remember that none of the message boards should be used for advertising or other business solication.